Form 483

ACS Dobfar SpA Form 483, 2014-03-18

FDA issued a Form 483 to ACS Dobfar SpA on 2014-03-18 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

ACS Dobfar SpA · Verona, Italy · Issued March 18, 2014

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Mar 2014
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Noreen Muniz

18 Mar 2014
21 CFR 211.100(b)

SOPs not followed / documented

Cited by Noreen Muniz

18 Mar 2014
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Noreen Muniz

18 Mar 2014
21 CFR 211.170(b)

Reserve samples identified, representative, stored

Cited by Noreen Muniz

18 Mar 2014
21 CFR 211.192

Written record of investigation incomplete

Cited by Noreen Muniz

Inspected site

ADACS Dobfar SpAVerona, Italy

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(b)Cited across public-safe Form 483 observations1x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere